AGP Picks
View all

Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on May 27, 2026

BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH
Lantronix Announces Preliminary Inclusion in Russell 3000® Index
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
Korro to Present at the 2026 Jefferies Global Healthcare Conference
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
Synack Named a Leader in G2’s Grid Report and Enterprise Grid Report for Penetration Testing, Summer 2026
Aurora Mobile's GPTBots.ai Upgrades AI Agents from Chat to Execution
Agora, the Denodo Cloud Service, now available on the Microsoft Marketplace to Power Agentic AI Use Cases
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences
Wevr and HTC Announce The Blu: Expedition Taiwan, First in Global Series of Immersive Ocean XR Experiences
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.48 Billion in 2026
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
Proofpoint Introduces Active Exploits Protection to Help Organizations Prioritize Vulnerability Patching for Real-World Attacks in the AI Era

Share this page:

Sign up for:

Wyoming Tech Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.